Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key role in the inflammatory response in plaque psoriasis.

Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable three-dimensional tissues that make up our bodies.

Icotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between ...

But I actually bought this house for free. In this video, I walk you through exactly how it happened - from strategy to paperwork to that final, jaw - dropping moment when I realized it cost me ...

Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...

The approach, which mimics how the body responds to a virus, could pave the way for a universal cancer vaccine.